Biomaterials and Scaffolds for Engineering Vascular Grafts and Blood Vessels

Timeslot: Friday, April 13, 2018 - 10:30am to 12:30pm
Track: Tissue Engineering
Room: Grand Ballroom C


In recent years, significant effort has been devoted to developing efficient therapeutic strategies for repair and regeneration of cardiovascular injures. In this regard, biomaterials have played an imperative role in successful delivery of cells and therapeutic compounds as well as in engineering of native like cardiovascular tissue substitutes. To develop proper treatment strategies for CVD, some of the challenges include vascularization of synthetic tissues, renewable cell sources, biomaterials that have similar features to the native cardiovascular tissues, and efficacy in preclinical models. In this session, we will include topics ranging from emerging biomaterials, strategies of vascularization of engineered constructs, and advances in cardiovascular tissue engineering that have shown progress in preclinical settings.


  • 10:30 a.m. 313. Enhanced Hemocompatibility of Ta-implanted ePTFE Vascular Grafts, C Park*, E Song, H Lee, M Lee, H Kim; Seoul National University, Seoul, Republic of Korea

  • 10:45 a.m. 314. Spatially Patterned Atheroprotective Vascular Grafts for Enhanced Patency, K Nakayama*(1), M Kawamura(1), H Wang(2), J Woo(1), N Huang(1); (1)Stanford University, Stanford, CA, (2)Veterans Affairs Palo Alto Health Care System, Palo Alto, CA

  • 11:00 a.m. 315. Resorbable Vascular Grafts Show Early Smooth Muscle Formation in a Porcine Dialysis Access Model, C Stowell*(1), D Celdran-Bonafonte(2), A Jarrouj(2), J Janda(2), Y Wang(1), P Roy-Chaudhury(2); (1)Cornell University, Ithaca, NY, (2)University of Arizona, Tuscon, AZ

  • 11:15 a.m. 316. An Elastomeric Scaffold Functionalized with SDF-1?/CXCL12 Via Covalently Linked Syndecan-4, H Warner*, W Wagner; Wake Forest University School of Medicine, Winston-Salem, NC

  • 11:30 a.m. 317. Multicellular Vascularized Engineered Tissues through User-Programmable Biomaterial Photodegradation, C Arakawa*, B Badeau, C DeForest, Y Zheng; University of Washington, Seattle, WA

  • 11:45 a.m. 318. Matrix Anisotropy in Cardiac Differentiation and Cell Sheeting, J Zoldan*, A Allen, L Suggs; The University of Texas at Austin, Austin, TX

  • 12:00 noon 319. The Therapeutic Effect of Fetuin-A on the Calcified State of Smooth Muscle Cells, J. Mosier*, R. Hybart, A. Kay, J. Stewart, C. Simpson; Mississippi State University, Mississippi State, MS

  • 12:15 p.m. 320. Chitosan-TAM Ccomplex for Long-term Monitoring of Tissue Oxygen Content, C Li*, Z Huang, N Gao, H Niu, J Guan; Ohio State University, Columbus, OH